{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:13:15Z","timestamp":1789863195216,"version":"4.0.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.vaccine.2018.02.038","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T10:00:25Z","timestamp":1524564025000},"page":"3876-3881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Epidemiology, clinical presentation, risk factors, intensive care admission and outcomes of invasive meningococcal disease in England, 2010\u20132015"],"prefix":"10.1016","volume":"36","author":[{"given":"Sydel R.","family":"Parikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazim","family":"Beebeejaun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamez N.","family":"Ladhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.02.038_b0005","unstructured":"Control E.C.f.D.P.a. Annual Epidemiological Report 2016 \u2013 invasive meningococcal disease; 2014. Available from: <http:\/\/ecdc.europa.eu\/en\/healthtopics\/meningococcal\/Pages\/Annual-epidemiological-report-2016.aspx> [cited 2017 25\/05\/2017]."},{"issue":"13","key":"10.1016\/j.vaccine.2018.02.038_b0010","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.vaccine.2016.02.014","article-title":"Global epidemiology of capsular group W meningococcal disease (1970\u20132015): multifocal emergence and persistence of hypervirulent sequence type (ST)-11 clonal complex","volume":"34","author":"Mustapha","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.038_b0015","doi-asserted-by":"crossref","unstructured":"Campbell H. et al. Targeted vaccination of teenagers following continued rapid endemic expansion of a single meningococcal group W clone (sequence type 11 clonal complex), United Kingdom 2015. Eur Surveill 2015;20(28).","DOI":"10.2807\/1560-7917.ES2015.20.28.21188"},{"issue":"10061","key":"10.1016\/j.vaccine.2018.02.038_b0020","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/S0140-6736(16)31921-3","article-title":"Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study","volume":"388","author":"Parikh","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2018.02.038_b0025","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3201\/eid2202.150369","article-title":"Effectiveness of meningococcal B vaccine against endemic hypervirulent Neisseria meningitidis W strain, England","volume":"22","author":"Ladhani","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2018.02.038_b0030","doi-asserted-by":"crossref","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.04.063","article-title":"Global epidemiology of meningococcal disease","volume":"27","author":"Harrison","year":"2009","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2018.02.038_b0035","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.vaccine.2017.03.007","article-title":"The epidemiology of invasive meningococcal disease in EU\/EEA countries, 2004\u20132014","volume":"35","author":"Whittaker","year":"2017","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2018.02.038_b0040","first-page":"129","article-title":"A short review of serogroup C meningococcal conjugate vaccines","volume":"5","author":"Campbell","year":"2010","journal-title":"Eur Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2018.02.038_b0045","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S1474-4422(12)70180-1","article-title":"Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study","volume":"11","author":"Viner","year":"2012","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1016\/j.vaccine.2018.02.038_b0050","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.3201\/eid2208.160128","article-title":"Meningococcal group W disease in infants and potential prevention by vaccination","volume":"22","author":"Parikh","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.038_b0055","article-title":"Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity in England from 1998\/99-2015\/16","author":"Campbell","year":"2017","journal-title":"Eurosurveillance"},{"issue":"1","key":"10.1016\/j.vaccine.2018.02.038_b0060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3201\/eid1801.110901","article-title":"Invasive meningococcal capsular group Y disease, England and Wales, 2007\u20132009","volume":"18","author":"Ladhani","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2018.02.038_b0065","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/cid\/ciu881","article-title":"Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales","volume":"60","author":"Ladhani","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2018.02.038_b0070","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jinf.2015.07.007","article-title":"Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage","volume":"71","author":"Lucidarme","year":"2015","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2018.02.038_b0075","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1017\/S0950268802007549","article-title":"National enhanced surveillance of meningococcal disease in England, Wales and Northern Ireland, January 1999-June 2001","volume":"129","author":"Shigematsu","year":"2002","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2018.02.038_b9005","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1128\/IAI.72.1.332-337.2004","article-title":"Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals","volume":"72","author":"Balmer","year":"2004","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2018.02.038_b9020","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2452","article-title":"Meningococcal B vaccine failure with a penicillin-resistant strain in a young adult on long-term eculizumab","volume":"140","author":"Parikh","year":"2017","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.vaccine.2018.02.038_b9030","doi-asserted-by":"crossref","DOI":"10.3201\/eid2307.170236","article-title":"Emergency meningococcal ACWY vaccination program for teenagers to control group W meningococcal disease, England, 2015\u20132016","volume":"23","author":"Campbell","year":"2017","journal-title":"Emerg Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18302123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18302123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T02:17:46Z","timestamp":1561515466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18302123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":18,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0264410X18302123"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.038","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology, clinical presentation, risk factors, intensive care admission and outcomes of invasive meningococcal disease in England, 2010\u20132015","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}